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Summary
Background Most studies of long-term exposure to outdoor fine particulate matter (PM2·5) and cardiovascular disease 
are from high-income countries with relatively low PM2·5 concentrations. It is unclear whether risks are similar in 
low-income and middle-income countries (LMICs) and how outdoor PM2·5 contributes to the global burden of 
cardiovascular disease. In our analysis of the Prospective Urban and Rural Epidemiology (PURE) study, we aimed to 
investigate the association between long-term exposure to PM2·5 concentrations and cardiovascular disease in a large 
cohort of adults from 21 high-income, middle-income, and low-income countries.
Methods In this multinational, prospective cohort study, we studied 157 436 adults aged 35–70 years who were 
enrolled in the PURE study in countries with ambient PM2·5 estimates, for whom follow-up data were available. Cox 
proportional hazard frailty models were used to estimate the associations between long-term mean community 
outdoor PM2·5 concentrations and cardiovascular disease events (fatal and non-fatal), cardiovascular disease mortality, 
and other non-accidental mortality.
Findings Between Jan 1, 2003, and July 14, 2018, 157 436 adults from 747 communities in 21 high-income, middle-
income, and low-income countries were enrolled and followed up, of whom 140 020 participants resided in LMICs. 
During a median follow-up period of 9·3 years (IQR 7·8–10·8; corresponding to 1·4 million person-years), we 
documented 9996 non-accidental deaths, of which 3219 were attributed to cardiovascular disease. 9152 (5·8%) of 
157 436 participants had cardiovascular disease events (fatal and non-fatal incident cardiovascular disease), including 
4083 myocardial infarctions and 4139 strokes. Mean 3-year PM2·5 at cohort baseline was 47·5 µg/m³ (range 6–140). In 
models adjusted for individual, household, and geographical factors, a 10 µg/m³ increase in PM2·5 was associated with 
increased risk for cardiovascular disease events (hazard ratio 1·05 [95% CI 1·03–1·07]), myocardial infarction 
(1·03 [1·00–1·05]), stroke (1·07 [1·04–1·10]), and cardiovascular disease mortality (1·03 [1·00–1·05]). Results were 
similar for LMICs and communities with high PM2·5 concentrations (>35 µg/m³). The population attributable fraction 
for PM2·5 in the PURE cohort was 13·9% (95% CI 8·8–18·6) for cardiovascular disease events, 8·4% (0·0–15·4) for 
myocardial infarction, 19·6% (13·0–25·8) for stroke, and 8·3% (0·0–15·2) for cardiovascular disease mortality. We 
identified no consistent associations between PM2·5 and risk for non-cardiovascular disease deaths.
Interpretation Long-term outdoor PM2·5 concentrations were associated with increased risks of cardiovascular disease 
in adults aged 35–70 years. Air pollution is an important global risk factor for cardiovascular disease and a need exists 
to reduce air pollution concentrations, especially in LMICs, where air pollution levels are highest.
Funding Full funding sources are listed at the end of the paper (see Acknowledgments).
Copyright © 2020 The Author(s). Published by Elsevier Ltd. This is an open access article under the CC BY-NC-ND 4.0 
license.
Introduction
Outdoor fine particulate matter (PM2·5) air pollution is an 
important global risk factor for cardiovascular disease.1,2 
The Global Burden of Diseases, Injuries, and Risk Factors 
Study (GBD) 20173 estimated that long-term exposure to 
ambient PM2·5 contributed to 2·9 million deaths (5·2% of 
all global deaths).Nearly 50% of these deaths were 
attributable to ischaemic heart disease and stroke, which 
occur primarily in low-income and middle-income 
countries (LMICs) where outdoor PM2·5 concentrations 
are especially high.4
Direct epidemiological evidence for an association 
between long-term PM2·5 exposure and cardiovascular 
disease risk is mostly based on studies from high-income 
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countries.5–7 Compared with LMICs, exposure to air 
pollu tion is substantially lower in high-income countries 
and the distribution of cardiovascular disease incidence 
and risk factors also differ, limiting direct extrapolation 
of relative and absolute risks from high-income countries 
to LMICs.8 Although studies from LMICs have found an 
association between cardiovascular disease mortality and 
short-term increases in PM2·5 air pollution,9 few studies 
of long-term PM2·5 effects have been done in these 
countries.10–14 For example, the global exposure mortality 
model for long-term PM2·5 exposure and mortality15 is 
based on pooled results from 41 cohort studies in 
16 countries, of which only one was conducted in an 
LMIC (China). Another study of all-cause mortality in 
China was published in 2018, which reported a hazard 
ratio (HR) of 1·08 (95% CI 1·06–1·09) per 10 µg/m³ 
PM2·5 increase.11 Furthermore, evidence on specific 
cardio vascular disease outcomes from LMICs is scarce. 
An important study in China found large associations 
between high PM2·5 concentrations and stroke incidence 
(HR 1·13 [95% CI 1·09–1·17] per 10 µg/m³ PM2·5 
increase).13 Future studies are needed to replicate these 
findings and to investigate all types of cardiovascular 
disease in settings with high PM2·5 concentrations in 
other LMICs.
In our analysis of the Prospective Urban and Rural 
Epidemiology (PURE) cohort study, we aimed to inves-
tigate the association between long-term exposure to 
PM2·5 concentrations and cardiovascular disease in a large 
cohort of adults from 21 high-income, middle-income, 
and low-income countries.
Methods
Study design and participants
The design and methods of the PURE study have been 
described previously16–18 and are summarised in the 
appendix (p 2). Our analysis included individuals aged 
35–70 years from 747 urban and rural communities 
from 21 low-income, middle-income, and high-income 
countries.16
The study was designed to include countries that 
represented a wide range of socioeconomic levels, on 
the basis of 2006 World Bank classifications at study 
entry. We included four high-income countries (Canada, 
Saudi Arabia, Sweden, United Arab Emirates), seven 
upper-middle-income countries (Argentina, Brazil, Chile, 
Malaysia, Poland, South Africa, Turkey), five LMICs 
(China, Colombia, Iran, Palestine, the Philippines), and 
five low-income countries (Bangladesh, India, Pakistan, 
Tanzania, Zimbabwe). We sampled communities, which 
comprised of urban neighbourhoods or rural villages, and 
several communities were identified within each centre to 
represent distinct geographical areas in each country. The 
study was coordinated by the Population Health Research 
Institute (Hamilton Health Sciences, Hamilton, ON, 
Canada) and approved by the Hamilton Health Sciences 
Research Ethics Board and local ethics committees at each 
centre.
Research in context
Evidence before this study
A growing body of evidence indicates an association between 
cardiovascular disease and ambient fine particulate matter 
(PM2·5) air pollution. However, few prospective studies of PM2·5 
and cardiovascular disease have been undertaken in developing 
countries, where 80% of the burden of cardiovascular disease 
occurs, or in populations exposed to high PM2·5 concentrations 
(eg, above the WHO interim health guideline of >35 µg/m³). 
To date, only five studies of long-term exposure and 
cardiovascular disease have been done in populations exposed 
to high PM2·5 concentrations, all of which were done in China. 
Furthermore, in many large studies, individual-level data were 
not available for other cardiovascular disease risk factors that 
might confound associations between PM2·5 and cardiovascular 
disease. The paucity of data on the impact of long-term 
exposure to air pollution on cardiovascular disease in most 
low-income and middle-income countries (LMICs), where levels 
of exposure are high, leads to substantial uncertainty in disease 
burden assessments.
Added value of this study
We prospectively studied 157 436 adults aged 35–70 years at 
enrolment from 21 low-income, middle-income, and high-
income countries within the Prospective Urban and Rural 
Epidemiology (PURE) study. We compared long-term outdoor 
PM2·5 concentrations for 747 urban and rural communities with 
a mean 3-year baseline PM2·5 concentration of 47·5 µg/m³ 
(range 6–140), thereby covering the majority of the global 
distribution of PM2·5 concentrations. We assessed associations 
between PM2·5 concentration and all cardiovascular disease 
events (fatal and non-fatal) and cardiovascular disease 
mortality, while adjusting for a comprehensive set of individual, 
household, and geographical covariates that were collected 
using a standardised protocol. We observed consistent increases 
in cardiovascular disease events and mortality across all PM2·5 
concentrations and in LMICs. The strongest association was 
identified between stroke and PM2·5. No consistent associations 
were observed for non-cardiovascular disease deaths. 
By capturing a diverse global population exposed to a wide 
range of PM2·5 concentrations and including standardised 
objective measures of cardiovascular disease risk factors, 
this study adds to our understanding of the global impacts of 
PM2·5 air pollution on cardiovascular disease burden.
Implications of all the available evidence
PM2·5 is an important global risk factor for cardiovascular 
disease, especially stroke. A need exists to reduce air pollution 
concentrations, especially in LMICs, where air pollution levels 
are highest.
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This analysis included 157 436 adults for whom 
follow-up data were available, from countries with 
ambient PM2·5 estimates.
Procedures
Data on a comprehensive set of individual and household 
cardiovascular disease risk factors were collected at 
study enrolment via standardised protocols. Individual 
variables were age, sex, smoking status, physical activity 
(assessed using the International Physical Activity 
Questionnaire),19 a healthy eating index (the PURE 
diet score), baseline cardio vascular disease and other 
chronic conditions, cardiovascular disease medication 
use at baseline, arterial hypertension, waist-to-hip ratio, 
INTERHEART risk score (a composite index of individual 
risk measures for future cardiovascular disease),20 level of 
education, and occupational class. Household variables 
were household wealth index (asset inventory)21 and 
primary use of dirty fuels (ie, solid fuels and kerosene) 
for cooking as a proxy for household air pollution.22 
Geographical covariates at the community, regional, and 
national level were location (urban or rural) for each 
community, country-level gross domestic product (GDP) 
per capita (stan dardised to US$), Night Light Development 
Index score (a glo bal proxy of population density and 
economic activity),23 and a measure of health-care access 
and quality (regional level for China and India; national 
level for other countries).24 All individual, household, and 
geographical variables are described in the appendix (p 3).
We contacted participants at least every 3 years to 
ascertain the occurrence of clinical events and vital 
status. Up to three attempts were made to interview all 
households, supplemented with administrative health 
record information when available.8,17 Data contains mor-
tality for 98·4% and non-fatal cardiovascular disease for 
94·1% of participants. All cardiovascular disease events 
were adjudicated by an expert committee in each country, 
and to ensure standard classification of events across 
all countries and over time, a selection of cases was also 
adjudicated centrally. Event definitions are described in 
the appendix (p 4).
Assessment of outdoor PM2·5 air pollution exposure
Our primary outdoor PM2·5 estimates were derived using 
a Bayesian hierarchical model that integrates PM2·5 
ground monitor measurements, satellite retrievals of 
aerosol optical depth, and chemical transport models.25 
This model had high prediction of existing ground based 
monitors (R²=0·91; root mean square error 10·7 µg/m³) 
and was used to estimate global exposures to PM2·5 for 
GBD 2017.3 3-year rolling mean PM2·5 estimates were 
available for 2000, 2005, 2010, and 2011–16 at an 
approximate spatial resolution of 11 × 11 km. We assigned 
predicted PM2·5 concentrations to global positioning 
system coordinates for the centre of each PURE commu-
nity at baseline using data for the nearest available 
proceding year (eg, 2016 baseline years were assigned 
2015 estimates, 2008 baseline years were assigned 
2005 estimates). We also did sensitivity analyses to 
investigate exposures on the basis of an approximate 
5-year mean PM2·5 concen tration before baseline and the 
mean PM2·5 concentration for the entire study period 
(2001–18). We also did additional sensitivity analyses 
using a separate widely accepted model of global PM2·5 
concen trations (appendix p 12).26
Outcomes
Outcomes for this analysis were cardiovascular disease 
events (fatal and non-fatal cardiovascular disease), myo-
cardial infarctions (fatal and non-fatal), strokes (fatal and 
non-fatal), cardiovascular disease deaths (death from 
myocardial infarction, stroke, heart failure, and unexpected 
death without other causes), all non-accidental deaths, and 
all non-cardiovascular disease deaths.
Statistical analysis
We modelled associations between community PM2·5 
concentrations and each event definition using Cox 
proportional hazards frailty models. Person-years of 
follow-up were calculated from study enrolment to the 
date of a non-fatal cardiovascular disease event, death, or 
most recent follow-up. The proportional hazards assump-
tion was assessed using stratified Kaplan-Meier curves 
with weighted Schoenfeld residuals. The community was 
included as a random intercept to account for within-
community clustering of individuals and the fact that 
PM2·5 was assessed at the community level. For missing 
indi vidual and household categorical variables, we included 
a missing data category in analyses. We present HRs and 
95% CIs per 10 µg/m³ increase in PM2·5.
We present incremental models adjusted for a compre-
hensive set of individual, household, and community 
factors. Model 1 included age, sex, baseline year, and a 
community random intercept. Model 2 included additional 
individual and household cardiovas cular disease risk 
factors determined a priori (smoking status, physical 
activity, the PURE diet index, baseline cardiovascular 
disease and chronic conditions, cardiovascular disease 
medication use, hypertension, INTERHEART risk score, 
education, occupational class, household wealth index, 
and dirty fuel use for cooking). Model 3 was our a priori 
preferred model adjusted for geographical covariates 
(urban or rural location, country baseline GDP per capita, 
Night Light Development Index score, and a Healthcare 
Access and Quality Index score). For Model 3, we assessed 
the shape of the concentration–response curve using risk 
functions that capture a variety of potentially non-linear 
associ ations,27 an approach used previously to estimate 
the global exposure–response association for PM2·5 and 
mortality.15 We also repeated models 1–3 with categorical 
PM2·5 quintiles, whereby the lowest PM2·5 quintile was the 
reference group. We ran models for all PURE partici-
pants (n=157 436) and participants residing in LMICs 
(n=140 020).
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The PURE cohort is distributed across diverse urban 
and rural communities, with unique local and regional 
contexts that can influence both PM2·5 concentrations 
and cardiovascular disease. We created two additional 
models to assess unmeasured community and centre 
confounding. Model 4 included all variables in model 3 
with a nested random intercept for communities by 
centre and subdivided by urban and rural areas (n=89), to 
control for the PURE urban–rural sampling method. 
Model 5 included all variables in model 3 plus centre-
specific urban–rural indicators, to control for unmea-
sured differences between centres and urban–rural areas.
We did subgroup analyses to assess potential differences 
in the associations between PM2·5 and cardiovascular 
disease using model 3. We stratified by subgroups of sex, 
age, smoking status, household wealth index, education, 
cooking fuel, urban–rural community context, country 
income status (high-income countries or upper-middle-
income countries vs LMICs or low-income countries), 
and PM2·5 concentrations relative to the WHO interim 
target (<35 µg/m³ or ≥35 µg/m³). Statistically significant 
differences (p<0·05) between strata were tested using 
interaction terms between subgroup variables and PM2·5.
We also did five additional types of sensitivity analyses to 
assess the robustness of our results. First, we ran models 
with different PM2·5 exposure periods including 5-year 
means at baseline and mean PM2·5 concentration between 
2001 and 2018. Second, we assessed results using a 
separate global PM2·5 exposure model, which included 
PM2·5 estimates from all sources and with dust and salt 
removed.26 Third, we restricted models on the basis of 
community size to evaluate potential differences in PM2·5 
exposure measurement error. Fourth, we examined the 
influence of community temperature, green space, and 
traffic related air pollution on PM2·5 model results 
(appendix p 4). Fifth, we examined incremental models by 
removing each covariate in model 3 to examine model 
sensitivity to individual covariates.
We calculated population-attributable fractions28 using 
HRs from model 3 and PURE community PM2·5 baseline 
estimates with a PM2·5 counterfactual of 10 µg/m³ (ie, the 
current WHO air quality guideline).
All analyses were done using SAS (version 9.4) and R 
(version 3.4.2) statistical software.
Role of the funding source
The funders of the study had no role in study design, 
data collection, data analysis, data interpretation, or 
writing of the report. The corresponding author had full 
access to all the data in the study and had final 
responsibility for the decision to submit for publication.
Results
Between Jan 1, 2003, and July 14, 2018, 157 436 adults 
from 21 high-income, middle-income, and low-income 
countries were enrolled and followed up, of whom 
140 020 partici pants resided in LMICs. The mean age of 
participants at enrolment was 50·2 years (SD 9·7) and 
58% of participants were women. During a median 
follow-up period of 9·3 years (IQR 7·8–10·8; corres-
ponding to 1·4 million person-years), we documented 
9996 non-accidental deaths, of which 3219 were attri-
buted to cardiovascular disease. Other com mon causes of 
classi fied death included cancers (19%), respiratory 
diseases (6%), infections (5%), renal disease (2%), and 
endocrine or metabolic diseases (2%). 9152 (5·8%) of 
157 436 par ticipants had cardiovascular disease events 
(fatal and non-fatal incident cardiovascular disease), 
including 4083 myocardial infarctions and 4139 strokes. 
The mean 3-year PM2·5 concentration at baseline was 
47·5 µg/m³ (SD 32·6), ranging from 6 µg/m³ in Vancouver 
(BC, Canada) to 140 µg/m³ in Jaipur (India; figure 1). PM2·5 
exposure quintiles were: quintile 1 (<17·3 µg/m³); quin -
tile 2 (>17·3–27·1 µg/m³); quintile 3 (>27·1–47·3 µg/m³); 
quintile 4 (>47·3–77·9 µg/m³); and quintile 5 (>77·9 µg/m³). 
Correlations between PM2·5 concentrations for 3-year 
Figure 1: Location of PURE communities and 2009–11 mean PM2·5 concentrations
(A) Map of PURE communities. (B) Histogram of 3-year mean PM2·5 concentrations at baseline for 157 436 PURE participants.
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Overall 
(n=157 436)
Quintile 1 
(n=31 283)
Quintile 2 
(n=30 776)
Quintile 3 
(n=31 512)
Quintile 4 
(n=31 687)
Quintile 5 
(n=32 178)
Ambient PM2·5 air pollution (µg/m³) 47·5 (32·5) 12·2 (3·7) 22·0 (2·9) 38·5 (4·9) 65·2 (8·9) 97·6 (17·7)
Total follow-up, person-years 1 410 528 281 059 263 513 299 450 275 899 290 607
Communities 747 139 113 180 147 168
Age, years 50·2 (9·7) 52·4 (9·4) 50·9 (9·6) 49·0 (9·7) 50·1 (9·5) 50·6 (10·3)
Sex
Women 91 243 (58·0%) 17 671 (56·5%) 18 943 (61·6%) 17 894 (56·8%) 18 534 (58·5%) 18 201 (56·6%)
Men 66 193 (42·0%) 13 612 (43·5%) 11 833 (38·4%) 13 618 (43·2%) 13 153 (41·5%) 13 977 (43·4%)
Smoking status*
Current 32 936 (20·9%) 5865 (18·8%) 4976 (16·2%) 7912 (25·1%) 7713 (24·3%) 6470 (20·1%)
Former 17 382 (11·0%) 7801 (24·9%) 4079 (13·3%) 2543 (8·1%) 1496 (4·7%) 1463 (4·6%)
Never 105 571 (67·1%) 17 454 (55·8%) 21 467 (69·8%) 20 842 (66·1%) 21 953 (69·3%) 23 855 (74·1%)
Physical activity*
Low 26 732 (17·0%) 3924 (12·5%) 5103 (16·6%) 5829 (18·5%) 5369 (16·9%) 6507 (20·2%)
Moderate 54 797 (34·8%) 9240 (29·5%) 9554 (31·0%) 10 879 (34·5%) 13 436 (42·4%) 11 688 (36·3%)
High 64 359 (40·9%) 15 826 (50·6%) 12 681 (41·2%) 12 353 (39·2%) 11 353 (35·8%) 12 146 (37·8%)
PURE diet score 4·0 (1·9) 4·9 (1·8) 4·3 (1·8) 3·6 (2·1) 3·4 (1·8) 3·7 (1·9)
Abdominal obesity† 74 917 (47·6%) 17 299 (55·3%) 14 841 (48·2%) 13 103 (41·6%) 14 509 (45·8%) 15 165 (47·1%)
INTERHEART risk score‡ 10·2 (5·8) 12·9 (6·2) 10·5 (5·9) 9·1 (5·6) 9·4 (5·3) 9·2 (5·3)
Chronic condition§ 29 674 (18·8%) 6867 (22·0%) 6765 (21·9%) 5983 (19·0%) 4746 (15·0%) 5313 (16·5%)
Cardiovascular disease at baseline 11 812 (7·5%) 2460 (7·9%) 2289 (7·4%) 2089 (6·6%) 2456 (7·8%) 2518 (7·8%)
Medications for cardiovascular 
disease (%)
26 089 (16·6%) 7973 (25·5%) 5315 (17·3%) 4719 (15·0%) 3929 (12·4%) 4153 (12·9%)
Hypertension 59 932 (38·1%) 13 425 (42·9%) 12 191 (39·6%) 9560 (30·3%) 11 699 (36·9%) 13 057 (40·6%)
Solid fuel use for cooking 40 227 (25·6%) 1174 (3·8%) 7192 (23·4%) 11 100 (35·2%) 12 536 (39·6%) 8225 (25·6%)
Education*
Primary school or less 67 255 (42·7%) 12 765 (40·9%) 11 696 (38·0%) 17 105 (54·3%) 14 660 (46·3%) 11 029 (34·3%)
Secondary school 59 564 (37·8%) 8544 (40·8%) 12 762 (41·5%) 10 152 (32·2%) 13 982 (44·1%) 14 124 (43·9%)
Post-secondary school 30 145 (19·2%) 9913 (31·7%) 6262 (20·4%) 4055 (12·9%) 2951 (9·3%) 6964 (21·6%)
Household wealth index*
Tertile 1 49 471 (31·4%) 11 439 (36·6%) 7489 (24·3%) 11 978 (38·0%) 10 713 (33·8%) 7852 (24·4%)
Tertile 2 51 213 (32·5%) 10 294 (32·9%) 10 959 (35·6%) 9363 (29·7%) 11 384 (35·9%) 9213 (28·6%)
Tertile 3 52 903 (33·6%) 9421 (30·1%) 12 018 (39·1%) 9588 (30·4%) 8446 (26·7%) 13 430 (41·7%)
Unskilled worker 32 045 (20·4%) 4406 (14·1%) 4221 (13·7%) 6339 (20·1%) 8581 (27·1%) 8498 (26·4%)
Area of residence
Urban 83 887 (53·3%) 16 310 (52·1%) 17 062 (55·4%) 17 042 (54·1%) 11 459 (36·2%) 22 014 (68·4%)
Rural 73 549 (46·7%) 14 973 (47·9%) 13 714 (44·6%) 14 470 (45·9%) 20 228 (63·8%) 10 164 (31·6%)
Country GDP per capita, $US 8488 (13 399) 25 622 (19 956) 5506 (3635) 5891 (9374) 2696 (1880) 2932 (4958)
Night Light Development Index 
score¶
29·3 (39·4) 18·9 (20·5) 37·5 (47·2) 19·1 (24·2) 22·6 (35·6) 48·1 (50·6)
Healthcare Access and Quality 
Index score||
65·1 (16·3) 77·4 (14·8) 58·8 (11·5) 55·6 (13·5) 68·2 (15·8) 65·6 (16·1)
Country income category**
High-income country 17 417 (11·1%) 14 410 (46·1%) 0 1489 (4·7%) 0 1518 (4·7%)
Upper-middle-income country 41 647 (26·5%) 15 714 (50·2%) 15 985 (51·9%) 8593 (27·3%) 1355 (4·3%) 0
Lower-middle-income country 63 712 (40·5%) 1159 (3·7%) 6928 (22·5%) 8793 (27·9%) 24 366 (76·9%) 22 466 (69·8%)
Low-income country 34 660 (22·0%) 0 7863 (25·6%) 12 637 (40·1%) 5966 (18·8%) 8194 (25·5%)
Data are mean (SD), n, or n (%). PM2·5 exposure quintiles were: quintile 1 (<17·3 µg/m³); quintile 2 (>17·3–27·1 µg/m³); quintile 3 (>27·1–47·3 µg/m³); quintile 4 
(>47·3–77·9 µg/m³); and quintile 5 (>77·9 µg/m³). GDP=gross domestic product. *Data were missing for these variables, thus values in columns do not sum to the overall 
column totals. †Defined as a waist-to-hip ratio of ≥0·9 for men and ≥0·85 for women. ‡Composite index of individual risk measures, whereby a higher index score equates 
to higher cardiovascular disease risk. §Baseline chronic conditions included cardiovascular disease, cancers, diabetes, chronic obstructive pulmonary disease, asthma, 
tuberculosis, and HIV/AIDS. ¶Proxy measure of local population density and economic activity, whereby a higher index score represents a larger population and higher 
economic activity. ||Measure based on causes of death that should not occur in the presence of effective health care (higher index scores equate to better healthcare). 
**Defined according to 2006 World Bank classification at time of study entry.
Table 1: Population characteristics of the study population overall and by PM2·5 concentration quintile
Articles
e240 www.thelancet.com/planetary-health   Vol 4   June 2020
baseline, 5-year baseline, study period mean, and 3-year 
means for 2005, 2010, and 2015 were high (r=0·98) and 
consistent across regions (appendix p 13). We therefore 
present results utilising our a priori main exposure 
measure, 3-year PM2·5 averages preceding cohort entry.
Individual, household, and geographical character-
istics varied significantly across PM2·5 quintiles (table 1). 
Measures associated with poverty were more prevalent 
at higher PM2·5 concentrations than lower PM2·5 concen-
trations, which was expected since 22 466 (69·8%) of 
32 178 individuals in the highest PM2·5 quartiles were 
from lower-middle-income countries and 8194 (25·5%) 
of 32 178 individuals were from low-income countries. 
Mean INTERHEART risk scores (12·9 [SD 6·2] vs 
9·2 [5·3]), the number of participants who were ever 
smokers (13 666 [43·7%] vs 7933 [24·7%]), and the num-
ber of individuals on cardiovas cular disease medication 
at baseline (7973 [25·5%] vs 4152 [12·9%]) were higher in 
the lowest PM2·5 quintile than the highest PM2·5 quintile.
In the entire PURE cohort (n=157 436), in model 3, a 
10 µg/m³ increase in PM2·5 was associated with an HR of 
1·05 (95% CI 1·03–1·07) for major cardiovascular disease 
events and 1·03 (1·00–1·06) for cardiovascular disease 
deaths (table 2). The largest association was observed for 
stroke (HR 1·07 [95% CI 1·05–1·10]). The findings for 
the LMIC models were similar to the analyses of the 
overall PURE cohort, with a slightly larger risk for stroke 
(HR 1·09 [95% CI 1·06–1·12]). No consistent associations 
were observed for PM2·5 and non-accidental mortality 
and non-cardiovas cular disease mortality in overall and 
LMIC models.
Model 4 incorporated a nested random effect of 
communities within centres and yielded generally similar 
results to model 3. In model 5, we included centre 
urban–rural areas (n=89) as indicator variables in the 
model to control for unmeasured differences between 
urban and rural areas within centres, as well as differences 
between centres. In all models, the risk for cardiovascular 
disease mortality (1·12 [95% CI 1·02–1·25]), non-acci-
dental mor tality (1·08 [1·01–1·15]), and non-cardiovascular 
disease mortality (1·05 [0·98–1·13]) increased per 10 µg/m³ 
increase in PM2·5. The risk for cardio vascular disease 
events also increased slightly (HR 1·08 [95% CI 1·01–1·16]). 
HR estimates were almost identical in the LMIC cohort. 
20 centre urban or rural clusters had no variation in PM2·5 
across communities, and thus were not included in 
model 5 (13 692 individuals from seven countries). The 
mean within-centre urban and rural PM2·5 range was 
7 µg/m³.
In model 3, linear and non-linear HR slopes for 
cardiovascular disease events, stroke, and myocardial 
infarction were similar, with increased risk observed 
Events, n Main models Models controlling for unmeasured 
contextual factors
Model 1 Model 2 Model 3 Model 4 Model 5
All countries (n=157 436)*
Major cardiovascular disease† 9152 1·09 (1·07–1·11) 1·08 (1·06–1·09) 1·05 (1·03–1·07) 1·05 (1·02–1·08) 1·08 (1·01–1·16)
Myocardial infarction 4083 1·07 (1·05–1·10) 1·06 (1·03–1·08) 1·03 (1·00–1·06) 1·04 (0·99–1·09) 1·11 (1·02–1·21)
Stroke 4139 1·13 (1·10–1·15) 1·12 (1·09–1·14) 1·07 (1·05–1·10) 1·07 (1·03–1·11) 1·11 (1·00–1·22)
Cardiovascular disease mortality 3219 1·07 (1·04–1·10) 1·04 (1·02–1·07) 1·03 (1·00–1·06) 1·05 (1·01–1·09) 1·12 (1·02–1·23)
Non-accidental mortality‡ 9996 1·01 (0·99–1·03) 0·99 (0·97–1·00) 0·98 (0·96–0·99) 0·98 (0·95–1·01) 1·08 (1·01–1·15)
Non-cardiovascular disease 
mortality
6777 0·96 (0·94–0·99) 0·94 (0·92–0·96) 0·94 (0·93–0·96) 0·94 (0·92–0·97) 1·05 (0·98–1·13)
LMICs (n=140 020)§
Major cardiovascular disease† 8374 1·09 (1·07–1·11) 1·10 (1·08–1·12) 1·05 (1·03–1·08) 1·05 (1·02–1·08) 1·09 (1·02–1·17)
Myocardial infarction 3699 1·07 (1·04–1·10) 1·08 (1·05–1·11) 1·02 (0·99–1·05) 1·04 (0·99–1·10) 1·11 (1·02–1·22)
Stroke 3849 1·14 (1·11–1·17) 1·15 (1·12–1·18) 1·09 (1·06–1·12) 1·07 (1·02–1·12) 1·12 (1·01–1·25)
Cardiovascular disease mortality 3108 1·02 (0·99–1·05) 1·03 (1·00–1·06) 1·03 (1·00–1·06) 1·05 (1·00–1·09) 1·12 (1·02–1·24)
Non-accidental mortality‡ 9451 0·97 (0·95–1·00) 0·97 (0·95–0·99) 0·98 (0·96–1·00) 1·00 (0·97–1·03) 1·08 (1·00–1·15)
Non-cardiovascular disease 
mortality
6343 0·93 (0·91–0·95) 0·93 (0·91–0·95) 0·95 (0·93–0·97) 0·96 (0·93–1·00) 1·06 (0·98–1·14)
Data are hazard ratios per 10 µg/m³ PM2·5 increase (95% CI). Model 1 included age, sex, baseline year, and community random effect. Model 2 included the same risk factors as 
model 1 with the addition of smoking status, physical activity, PURE diet index score, waist-to hip ratio, INTERHEART risk score, use of solid fuels for cooking, education level, 
household wealth index, occupational class, baseline cardiovascular disease and chronic conditions, cardiovascular disease medication use, and hypertension (determined 
a priori). Model 3 included all the variables in model 2, with the addition of geographical covariates (urban or rural location, baseline country gross domestic product per capita, 
Night Light Development Index score, and a national or regional Healthcare Access and Quality Index). Model 4 included all the variables in model 3 with the addition of a 
nested random intercept for each community by centre (subdivided by urban and rural areas). Model 5 included all the variables in model 3, with the addition of an indicator 
variable for each centre urban–rural area. LMICs=low-income and middle-income countries. *Argentina, Bangladesh, Brazil, Canada, Colombia, Chile, China, India, Iran, 
Malaysia, Palestine, Pakistan, Philippines, Poland, South Africa, Saudi Arabia, Sweden, Tanzania, Turkey, United Arab Emirates, and Zimbabwe. †Death from cardiovascular 
causes and non-fatal myocardial infarction, stroke, and heart failure; each subcategory includes fatal and non-fatal events. ‡All deaths excluding injuries. §Argentina, 
Bangladesh, Brazil, Colombia, Chile, China, India, Iran, Malaysia, Palestine, Pakistan, Philippines, Poland, Saudi Arabia, South Africa, Tanzania, Turkey, and Zimbabwe.
Table 2: Associations between 3-year mean outdoor PM2·5 concentration at baseline and cardiovascular disease events and mortality
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across the entire range of PM2·5 (figure 2). For cardio-
vascular disease mortality, the non-linear HR followed 
an exponential distribution, with a small HR slope 
below 80 µg/m³ followed by increases between 80 and 
140 µg/m³. Repeating models 1–3 with PM2·5 quintiles as 
categorical exposures provided additi onal insight with 
regard to non-linear associations between PM2·5 and 
cardiovascular disease (appendix p 15). In model 2, HRs 
for cardiovascular disease mortality, major cardiovascular 
disease events, myo cardial infarc tion, and stroke all 
had concentration–response relation ships. However, the 
concentration–response was only present for stroke 
and major cardiovascular disease events after accounting 
for geo graphical variables. The HR for stroke, using 
quintile 1 as the reference, was 0·83 (95% CI 0·64-1·07) 
for quintile 2, 1·25 (0·98–1·58) for quintile 3, 1·41 
(1·09–1·84) for quintile 4, and 1·75 (1·31–2·32) for 
quintile 5 (appendix p 15).
Subgroup analyses of cardiovascular disease events 
showed risk was consistent when stratified by individual, 
household, and geographical characteristics (table 3). 
The risk for cardiovascular disease, myocardial infarction, 
stroke, and cardiovascular disease mortality, was fairly 
similar for women and men, ever and never smokers, 
and across levels of education and wealth. At baseline, 
11 812 (7·5%) of 157 436 participants had cardiovascular 
disease. The risk for cardiovas cular disease events was 
slightly higher for individuals without cardiovascular 
disease at base line (1·05 [95% CI 1·03–1·08]) than indivi-
duals with cardiovascular disease at baseline (1·03 
[1·01–1·06]). Although mean PM2·5 was slightly higher in 
urban communities (49·3 µg/m³ [SD 35·0]) compared 
with rural communities (45·4 µg/m³ [29·3]), larger 
associations between mean PM2·5 concentration and stroke 
were observed in rural communities (HR 1·13 [95% CI 
1·09–1·18]) than urban communities (1·05 [1·01–1·09]). 
The risk for cardiovascular disease events was greater 
for high-income countries or upper-middle-income 
countries (HR 1·14 [95% CI 1·07–1·21]) than LMICs or 
low-income countries (1·05 [1·02–1·07]) or middle-
income countries alone (1·07 [1·04–1·11]). When stratified 
by the WHO interim target of 35 µg/m³, the risk for 
cardiovascular disease events was higher in areas with 
PM2·5 concentrations of less than 35 µg/m³ (HR 1·15 
[95% CI 1·02–1·29]) than areas with PM2·5 concentrations 
of 35 µg/m³ or higher (1·05 [1·02–1·08]).
Sensitivity analyses demonstrate the robustness of our 
results (appendix p 17). The correlations between dif-
ferent PM2·5 exposure periods (r>0·98) and an indepen-
dent PM2·5 prediction model (r>0·85) were high and 
consistently show increased cardiovascular disease risk 
with different PM2·5 metrics in models 3 and 5. The 
addition of environmental exposure variables (commu-
nity temperature, green space, and traffic related air 
pollution) to model 3 did not change HRs for cardio-
vascular disease events but increased the risk for 
cardiovascular disease mortality (HR 1·07 [95% CI 
1·04–1·10]). Removing the largest communities and 
missing data categories did not change model results. 
When the community random intercept was removed 
from model 3, the risk for cardiovascular disease events 
was reduced (HR 1·03 [95% CI 1·03–1·04]), but was 
increased in model 5. Incrementally removing variables 
from model 3 showed that our results are not sensitive to 
specific individual variables, but removal of geographical 
variables, especially country GDP, increased the risk for 
cardiovascular disease (appendix p 19). We calculated 
population-attributable fractions separately for fatal and 
non-fatal cardiovascular disease events, myocardial infarc-
tion, stroke, and cardiovascular disease mortality on the 
basis of the HRs from model 3 (appendix p 21). Using 
the WHO reference exposure concen tration of 10 µg/m³, 
the PM2·5 population-attributable fractions for the PURE 
cohort were 13·9% (95% CI 8·8–18·6) for cardiovascular 
disease events, 8·4% (0·0–15·4) for myocardial infarction, 
19·6% (13·0–25·8) for stroke, and 8·3% (0·0–15·2) for 
cardiovas cular disease mortality.
Discussion
In this prospective cohort study, long-term outdoor 
PM2·5 was consistently associated with increased risk 
for cardiovascular disease. Models for deaths were 
sensitive to adjustment for geographical factors and no 
consistent association was observed for non-cardio-
vascular disease deaths. Our study included a diverse 
population residing in LMICs, and thus our results 
Figure 2: Non-linear exposure–response functions for cardiovascular disease mortality (A), all cardiovascular 
disease events (B), stroke (C), and myocardial infarction (D) based on model 3
Cardiovascular disease events included fatal and non-fatal events. Red lines show linear hazard ratio estimates and 
blue lines show non-linear hazard ratio estimates. Shaded areas represent 95% CIs for the non-linear models.
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provide new information about associations between 
ambient PM2·5 and cardio vascular disease across a 
much wider range of PM2·5 concentrations (6–140 µg/m³) 
than reported previously.
Our results suggest cardiovascular disease risk increases 
across the global range of PM2·5. A 2018 meta-analysis 
identified 53 studies of long-term PM2·5 and cardiovascular 
disease mortality, of which only six studies were done 
outside North America or Europe.29 Mean PM2·5 concen-
tration in all studies was 15·7 µg/m³, lower than the 
mean of 47·5 µg/m³ in PURE.29 The meta-regression 
estimate for a 10% increase in PM2·5 at a mean exposure of 
10 µg/m³ was a 14·6% (95% CI 12·5–16·7%) increase in 
cardiovascular disease mortality. This meta-analysis also 
identified that at higher PM2·5 concentrations the risks 
were reduced, but few studies were available for PM2·5 
concentrations higher than 35 µg/m³. Only one mortality 
study from LMICs was included (n=189 793 men 
from 45 areas in China), where an HR of 1·09 (95% CI 
1·08–1·09) for cardiovascular disease mortality per 
10 µg/m³ increase in PM2·5 was observed.10 Our study 
addresses this important data gap by suggesting that 
the risk for cardiovascular disease events (including both 
fatal and non-fatal events) and cardiovascular disease 
deaths increase at high PM2·5 concentrations. We observed 
positive associations with cardiovascular disease events 
 Participants 
(n=157 436)
 Cardiovascular 
disease
Myocardial infarction Stroke Cardiovascular disease 
mortality
Overall (model 3) 157 436 (100%) 1·05 (1·03–1·07) 1·03 (1·00–1·06) 1·07 (1·05–1·10) 1·03 (1·00–1·06)
Sex
Women 91 243 (58%) 1·07 (1·04–1·10)* 1·05 (1·01–1·09)* 1·08 (1·05–1·12) 1·04 (1·00–1·07)*
Men 66 193 (42%) 1·03 (1·01–1·05)* 1·00 (0·97–1·03)* 1·06 (1·03–1·09) 1·01 (0·98–1·03)*
Age, years
≤60 128 171 (81%) 1·03 (1·01–1·06)* 1·01 (0·98–1·04) 1·07 (1·04–1·10) 1·02 (0·98–1·05)
>60 29 266 (19%) 1·06 (1·03–1·08)* 1·03 (1·00–1·07) 1·06 (1·03–1·10) 1·02 (0·99–1·06)
Baseline cardiovascular disease
Yes 11 812 (8%) 1·03 (1·00–1·06)* 1·00 (0·97–1·05) 1·04 (0·98–1·08)* 1·03 (0·98–1·07)
No 145 624 (92%) 1·05 (1·03–1·08)* 1·03 (1·00–1·06) 1·08 (1·05–1·11)* 1·02 (1·00–1·05)
Smoking status
Never smoker 105 571 (68%) 1·06 (1·04–1·09)* 1·04 (1·00–1·07)* 1·09 (1·06–1·12)* 1·06 (1·02–1·09)*
Ever smoker 50 318 (32%) 1·03 (1·00–1·05)* 0·99 (0·96–1·02)* 1·06 (1·02–1·09)* 0·98 (0·95–1·01)*
Household Wealth Index
Lowest 49 471 (32%) 1·08 (1·05–1·11) 1·06 (1·02–1·11) 1·08 (1·04–1·12) 1·04 (1·00–1·08)
Middle 51 213 (33%) 1·03 (1·01–1·06) 1·00 (0·96–1·04) 1·07 (1·03–1·11) 0·99 (0·96–1·03)
Highest 52 903 (34%) 1·03 (1·00–1·06) 1·01 (0·98–1·05) 1·06 (1·02–1·10) 1·02 (0·98–1·06)
Education
Primary or less 67 255 (43%) 1·07 (1·04–1·09)* 1·05 (1·01–1·08)* 1·08 (1·05–1·12) 1·02 (1·00–1·06)
Secondary school or higher 89 706 (57%) 1·02 (1·00–1·05)* 0·98 (0·96–1·01)* 1·05 (1·02–1·09) 1·00 (0·97–1·04)
Household air pollution
Clean fuel 109 305 (74%) 1·04 (1·02–1·06) 1·01 (0·98–1·04) 1·06 (1·02–1·09) 1·00 (0·97–1·04)
Dirty fuel 40 227 (26%) 1·06 (1·03–1·09) 1·03 (0·99–1·07) 1·10 (1·05–1·14) 1·03 (1·00–1·07)
Community location
Urban 83 887 (53%) 1·03 (1·01–1·06)* 1·02 (0·99–1·05) 1·05 (1·01–1·09)* 1·02 (0·98–1·05)
Rural 73 549 (47%) 1·09 (1·05–1·12)* 1·04 (0·99–1·09) 1·13 (1·09–1·18)* 1·05 (1·01–1·09)
Country income category
High income or UMIC 59 064 (38%) 1·14 (1·07–1·21)* 1·11 (1·03–1·21)* 1·08 (1·00–1·18)* 0·91 (0·82–1·01)*
LMIC or low income 98 372 (62%) 1·05 (1·02–1·07)* 1·01 (0·98–1·05)* 1·10 (1·06–1·13)* 1·03 (1·00–1·07)*
WHO interim health target†
<35 µg/m³ 69 862 (44%) 1·15 (1·02–1·29) 0·98 (0·84–1·17) 1·36 (1·16–1·58) 1·09 (0·93–1·29)
≥35 µg/m³ 87 574 (56%) 1·05 (1·02–1·08) 1·04 (1·00–1·08) 1·05 (1·01–1·10) 1·09 (1·04–1·13)
Data are n (%) or hazard ratio per 10 µg/m³ PM2·5 increase (95% CI). Model 3 included the following variables: age, sex, baseline year, smoking status, physical activity, 
PURE diet index score, waist-to-hip ratio, INTERHEART risk score, use of solid fuels for cooking, education level, household wealth index, occupational class, baseline 
cardiovascular disease and chronic conditions, cardiovascular disease medication use, hypertension, and geographical covariates (urban or rural location, baseline country 
gross domestic product per capita, Night Light Development Index score, and a national or regional Healthcare Access and Quality Index. UMIC=upper-middle-income 
country. LMIC=low-income and middle-income country. *Statistically significant differences (p<0·05) between strata were tested using interaction terms between subgroup 
variables and PM2·5. †Models restricted to PM2·5 concentrations above and below the WHO interim health target of 35 µg/m³.
Table 3: Subgroup analyses for the associations of PM2·5 with cardiovascular disease, myocardial infarction, stroke, and cardiovascular disease mortality
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(HR 1·05 [95% CI 1·03–1·07]) and cardiovascular disease 
mortality (1·03 [1·00–1·05]) per 10 µg/m³ increase in 
PM2·5. After con trolling for unmeasured contextual 
factors, the HR for all cardiovascular disease events 
increased to 1·08 (95% CI 1·01–1·16). These estimates are 
smaller than previous estimates and might be associated 
with differences in PM2·5 exposure ranges assessed; the 
distribution of cause-specific mortality in PURE compared 
with studies done in North America and Europe; a greater 
extent of covariate adjustment in our study compared with 
the previous studies; and exposure measurement error 
associated with the diverse range of communities included 
in the PURE study, which could attenuate results. 
However, across the full range of PM2·5 concentrations, 
we observed consistently increased risks for models 
restricted to LMICs, for populations exposed to long-term 
PM2·5 concentrations of 35 µg/m³ or higher (the WHO 
interim target), and in models restricted to within-locality 
comparisons.
Stroke was most strongly associated with PM2·5 in our 
study (HR 1·07 per 10 µg/m³ increase in PM2·5 [95% CI 
1·05–1·10]). These finding contribute to a growing body 
of literature that identifies stroke as a potentially impor-
tant outcome affected by PM2·5, especially at high PM2·5 
concentrations. A study of stroke mortality within the 
China-PAR project13 reported an HR of 1·13 (95% CI 
1·09–1·17) for all incident strokes per 10 µg/m³ increase 
in PM2·5 (n=17 575 individuals in 15 provinces), and 
increased risks for ischaemic stroke and haemorrhagic 
stroke separately. A separate study in Hong Kong 
found an increased risk for ischaemic strokes (HR 1·21 
[95% CI 1·04–1·41]), but no association with haemor-
rhagic stroke.14 Although we were unable to assess stroke 
subtypes in PURE, in combination with studies from 
high-income countries,30,31 our study results strengthen 
the evidence of increased stroke risk with high PM2·5 
concentrations.
We found no consistent associations between PM2·5 
concentrations and non-accidental mortality or non-
cardiovascular disease mortality. We observe increased 
risks in models with locality indicators, suggesting that 
unmeasured contextual factors influence mortality. For 
example, the risk for non-cardiovascular disease deaths 
was lower in model 3 (HR 0·94 [95% CI 0·93–0·96]) 
than model 5 (1·05 [0·98–1·13]). Although consistent 
associations with non-accidental and non-cardio vascular 
disease mortality have been reported,15,29 this might be 
associated with differences in the distri bution of mortality 
causes in high-income countries compared with that of 
the LMIC populations included in the PURE cohort. Of 
the 9996 non-accidental deaths recorded during follow-
up, approximately 32% were attributed to cardiovascular 
disease. Other com mon causes of classified death 
included cancers (19%), respiratory diseases (6%), infec-
tions (5%), renal disease (2%), and endocrine or metabolic 
diseases (2%). Associations between PM2·5 and specific 
non-cardiovascular disease mortality will be investigated 
in future studies, as additional events (including non-fatal 
events) accrue during follow-up.
Our estimated population-attributable fraction for PM2·5 
and cardiovascular disease within the PURE population 
suggests substantial contributions to disease burden: 
8·3% (95% CI 0·0–15·2) for cardiovascular disease 
mortality; 13·9% (8·8–18·6) for cardiovascular disease 
events; 8·4% (0·0–15·4) for myocardial infarction; and 
19·6% (13·0–25·8) for stroke using a reference of 10 µg/m³ 
(the current WHO PM2·5 air quality guideline). These 
population-attributable fraction estimates have large con-
fidence intervals and thus should be inter preted with 
caution. Our estimates are generally comparable to the 
GBD 2017 for cardio vascular disease deaths (8%), 
cardiovascular disease disability-adjusted life-years (9%), 
ischaemic heart disease (13%), and stroke (8%), which used 
a counterfactual distribution of PM2·5 of 2·5–5·9 µg/m³.32 
However, we did not observe consistent associations 
with non-cardiovascular disease deaths, which constitute 
over 50% of the estimated attributable deaths to outdoor 
PM2·5 in the GBD estimates.4 Compre hensive analyses of 
different population-attributable fractions for modifiable 
cardiovascular disease risk factors within the PURE study 
(eg, behavioural, metabolic, and socioeconomic risk fac-
tors) provide relative comparisons for our PM2·5 population-
attributable fraction estimates.33 Although PURE is not 
representative of the global population (and therefore 
should not be interpreted as representing the global 
population-attributable frac tion from PM2·5 air pollution), 
our results suggest that long-term outdoor PM2·5 is an 
important contributor to cardiovascular disease globally.
The strengths of this study include the diverse 
population included, which enabled investigation of a 
wide range of PM2·5 concentrations across 21 countries 
spanning from low-income countries to high-income 
countries; uniform assessment of long-term PM2·5 using 
state-of-the art exposure estimation methods; objective 
measurement of a comprehensive suite of individual 
cardiovascular disease risk factors and standardised data 
collection for household and community characteristics; 
and prospective recording of fatal and non-fatal events 
that were adjudicated using standard definitions. 
However, our study also had limitations. First, we were 
unable to control for the daily or seasonal variations in 
PM2·5 exposures, and we did not have annual estimates 
before 2010. However, PM2·5 concentrations for PURE 
communities were highly correlated (r=0·98) for these 
different time periods and sensitivity analyses using 
another PM2·5 prediction model with annual estimates 
revealed similar results. Second, we assigned PM2·5 by 
study community (eg, urban neighbourhoods and rural 
villages). Although outdoor PM2·5 concentrations are not 
likely to vary substantially, exposure misclassification 
might be present and our analyses are driven by between-
community PM2·5 differences. Third, we were only able 
to examine PM2·5 mass, but the composition of PM2·5 is 
likely to vary substantially across PURE communities. In 
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sensitivity analyses examining PM2·5 mass estimates with 
salt and dust removed, we observed larger associations 
with cardiovascular disease events and stroke, but no 
associations with myocardial infarction or cardio vascular 
death. We controlled for household air pollution using 
a survey-based indicator of cooking with dirty fuels. 
Quantitative assessment of PM2·5 concen trations from 
household air pollution has been incorporated into a 
subset of the PURE cohort,34 and will be incorporated 
into future analyses with extended follow-up. Fourth, 
models were also sensitive to geo graphical adjustments. 
We have previously shown how diseases and deaths vary 
by economic status in the PURE study,8 and PM2·5 
concentrations are also associated with economic status. 
However, models that further controlled for unmeasured 
geographical factors resulted in slightly larger HRs for 
cardiovascular disease events and considerably higher 
HRs for non-accidental and non-cardiovascular disease 
mortality. Our results from model 3 might therefore be a 
conservative estimate of the association between long-
term PM2·5 and cardiovascular disease.
Long-term ambient PM2·5 was positively associated with 
cardiovascular disease events, especially stroke, in this 
large and diverse prospective cohort study. Our results 
provide new information about the associations between 
ambient PM2·5 and cardiovascular disease across a much 
wider range of PM2·5 concentrations (6–140 µg/m³) than 
reported previously, and within a diverse population 
residing in LMICs, while adjusting for an extensive set of 
individual, household, and community cardiovascular 
disease risk factors. These findings reinforce the need to 
reduce air pollution in all countries, especially in LMICs 
where air pollution levels are highest.
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